• Immunogenicity Assessment

    • Therapeutic In Silico Services
      • ISPRI™ Website
      • ISPRI Downselect™
      • ISPRI Quantify™
      • ISPRI Analyze™
      • ISPRI Evaluate™
      • ISPRI-HCP™
      • ISPRI Design™
      • PANDA® Screening
    • Vaccine In Silico Services
      • iVAX™
      • EpiCC™
      • Ancer®
      • PreVAX™
    • Lab Services
      • HLA Binding Assay
      • Naive CD4+ T Cell Assay
      • Innate Assay
    • Consulting Services
  • About Us
    • Leadership
    • Careers
  • Partner
  • Press
    • News
    • Events
    • Publications
  • Contact Us

A novel algorithm for the efficient identification of T cell epitopes: prediction and testing of candidate TB vaccine peptides in genetically diverse populations

by Adam | Oct 22, 2016

Vaccines 96, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, pp. 127-134.
Analyzing Mycobacterium tuberculosis proteomes for candidate vaccine epitopes

Analyzing Mycobacterium tuberculosis proteomes for candidate vaccine epitopes

by Adam | Oct 22, 2016

Tuberculosis (Edinb). 2005; 85(1-2):95-105.

Recent Posts

  • Thinking Out Loud: January 2025
  • Artificial Intelligence / Human Intelligence Workshop 2025
  • Thinking Out Loud: December 2024
  • EpiVax Drives Immunogenicity Innovation in 2024: Year in Review
  • Supporting Health Equity: EpiVax Highlights Partnerships and New Research from Clínica Esperanza and GAIA Vaccine Foundation

Recent Comments

No comments to show.

Join our newsletter

 Stay up to date with EpiVax and greater industry news, events, and technological advancements with this monthly update written by EpiVax co-founder and CSO, Dr. Annie De Groot. 

Explore

Therapeutic In Silico Services

Vaccine In Silico Services

Lab Services

Consulting

LinkedIn

About Us

Careers

Partner

News

Events

Publications

Contact Us

We use cookies to ensure that we give you the best experience on our website. By clicking 'accept', you consent to our use of cookies.AcceptDecline